Rapid Progressive Glomerulonephritis

Rapid progressive glomerulonephritis (RPGN) (synonyms: Glomerulonephritis, rapidly progressive; English rapidly progressive glomerulonephritis ICD-10 N01.-: Rapid-progressive nephritic syndrome) is a relatively rare form of glomerulonephritis with rapidly progressive (progressive) deterioration of kidney function.

Glomerulonephritis is bilateral inflammation of the kidneys in which the renal corpuscles (glomerules) are affected first.

It is a nephrological emergency that must be clarified and treated, otherwise renal insufficiency may develop (within days to weeks).

The following main forms of glomerulonephritis are distinguished:

Rapid progressive glomerulonephritis (RPGN) is divided into the following types:

  • Type 1: 12% of cases; due to antibodies against the glomerular basement membrane.
  • Type 2: 44% of cases; caused by deposition of immune complexes; occurs, for example, in the presence of lupus erythematosus (LE)
  • Type 3: 44% of cases; immune complexes and antibasal membrane antibodies are absent.

The incidence (frequency of new cases) is approximately 1 disease per 100,000 inhabitants per year (in Germany).

Course and prognosis: If left untreated, the rapid (rapidly) progressive glomerulonephritis leads to terminal renal failure (kidney failure). If therapy is started early, i.e., the kidneys still have residual function, renal function improves in more than 60% of cases.

Types 2 and 3 of rapid progressive glomerulonephritis are often recurrent (recurring).